BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26262458)

  • 1. Chronic lung allograft dysfunction: evolving practice.
    Vos R; Verleden SE; Verleden GM
    Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current views on chronic rejection after lung transplantation.
    Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
    DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
    Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
    Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
    Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms.
    Royer PJ; Olivera-Botello G; Koutsokera A; Aubert JD; Bernasconi E; Tissot A; Pison C; Nicod L; Boissel JP; Magnan A;
    Transplantation; 2016 Sep; 100(9):1803-14. PubMed ID: 27257997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M
    Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.
    Hota P; Dass C; Kumaran M; Simpson S
    AJR Am J Roentgenol; 2018 Jul; 211(1):W13-W21. PubMed ID: 29792746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
    Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update in Chronic Lung Allograft Dysfunction.
    Shah RJ; Diamond JM
    Clin Chest Med; 2017 Dec; 38(4):677-692. PubMed ID: 29128018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of Personalized and Targeted Preventive Therapies for Chronic Lung Allograft Dysfunction Subtypes;A Novel Strategy].
    Saito T; Sato M; Taniguchi Y; Murakawa T; Keshavjee S
    Kyobu Geka; 2016 Oct; 69(11):931-934. PubMed ID: 27713199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
    Verleden GM; Godinas L; Vos R; Verleden SE
    Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lung allograft dysfunction: light at the end of the tunnel?
    Verleden SE; Vos R; Verleden GM
    Curr Opin Organ Transplant; 2019 Jun; 24(3):318-323. PubMed ID: 31090642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.